NovaBridge Biosciences chief commercial officer Mark Arnold Hagler reports $85,864 common share acquisition
NBP•Chief Commercial Officer Mark Arnold Hagler purchased 230,000 NovaBridge Biosciences ordinary shares in two transactions, at $0.343 and $0.381 per share. His direct beneficial ownership rose to 460,000 shares.
1. Share purchases
Hagler purchased 46,000 ordinary shares at $0.343 each and 184,000 at $0.381 each. His direct beneficial ownership increased to 460,000 ordinary shares.




